WHAT: “Missing The Target: When Practitioners Harm More Than Heal.”
PharmedOut, a Georgetown University Medical Center-based pharmaceutical marketing research project, hosts its highly-acclaimed third annual conference focusing on the misinformation and patient harm that can occur from pharmaceutical and medical device marketing.
• Rita Redberg M.D., M.Sc., Archives of Internal Medicine Editor-in-Chief; professor of medicine, University of California, San Francisco
• Carl Elliott M.D. Ph.D., author, White Coat, Black Hat; professor, University of Minnesota’s Center for Bioethics
• Kay Dickersin Ph.D., director, Center for Clinical Trials, Johns Hopkins Center for Global Health
• Julie Taitsman M.D., J.D., chief medical officer, Office of the Inspector General, U.S. Department of Health and Human Services
• Sharon Treat J.D., executive director, National Legislative Association on Prescription Drug Prices
• Joel Lexchin M.D., professor, York University
• Donald Light Ph.D., professor, University of Medicine and Dentistry of New Jersey
For a full list of speakers and topics, visit pharmedout.org.
WHEN: Thursday, June 14 and Friday, June 15, 2012, 8:00 a.m. to 5:30 p.m. ET.
Thursday morning: Marketing of antipsychotic medications and other drugs
Thursday afternoon: Potential health risks of CT scans and other medical devices
Friday morning: Legislative and regulatory updates and solutions
Friday afternoon: Informing and protecting patients: The role of industry, media, and payers
WHERE: Lohrfink Auditorium in the Hariri Building, Georgetown University, 37th and O Streets, N.W., Washington, D.C., 20057.
Complimentary registration is available for credentialed journalists by contacting Karen Mallet (contact information above.)
Funding for the conference is provided by Georgetown University Medical Center, the Southern Network on Adverse Reactions, and individual donations.
PharmedOut is an education and research project involving volunteer physicians, nurses, scientists, industry insiders and students based at Georgetown University Medical Center. PharmedOut educates health care professionals about pharmaceutical marketing practices, encourages the use of unbiased information about medications, and supports evidence-based prescribing. PharmedOut is funded by individual donations. For more information, visit the website at pharmedout.org.
About Georgetown University Medical Center
Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC’s mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing & Health Studies, both nationally ranked; Georgetown Lombardi Comprehensive Cancer Center, designated as a comprehensive cancer center by the National Cancer Institute; and the Biomedical Graduate Research Organization (BGRO), which accounts for the majority of externally funded research at GUMC including a Clinical Translation and Science Award from the National Institutes of Health. In fiscal year 2010-11, GUMC accounted for 85 percent of the university’s sponsored research funding.